Bringing the fundamentals into focus…
Back to Vertex Pharmaceuticals Incorporated
How Vertex Pharmaceuticals Incorporated stacks up
VRTX · against 26 other Healthcare companies of similar size
Growth
58/ 100
Above the middle of the pack.
Ranked #12 of 27 · scores higher than 54% of peers
Bars: peers in each 10-point band of the growth score4 peers with a growth score of 50–59, including VRTX · Click a bar to see the companies
Why growth scores 58?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- faster revenue growth over three years: stronger than 62% of peers. 3-year revenue growth: 9.8% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 62% of peers. Revenue growth: 10.2% vs peer median 6.1%
- faster growth in earnings per share: stronger than 64% of peers. Earnings per share growth: 22.5% vs peer median 9.8%
Metric by metric
Position: dot = VRTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VRTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 27 reported | 10.2% | 7.3% | 92% | 33% | |
| Earnings per share growthHigher is better · 26 reported | 22.5% | 22.3% | 52% | 33% | |
| 3-year revenue growthHigher is better · 27 reported | 9.8% | 5.0% | 77% | 33% |
Ranking by growth score
Top 5 and the companies ranked around VRTX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 126.5B USD | 78 | 56 | |
| 2 | 534.1B HKD (≈$68.4B) | 76 | 75 | |
| 3 | 155.7B USD | 73 | 64 | |
| 4 | 540.4B BRL (≈$97.3B) | 72 | 64 | |
| 4 | 97.5B USD | 72 | 67 | |
| 9 | 249.4B USD | 63 | 55 | |
| 9 | 126.1B USD | 63 | 62 | |
| 11 | 177.5B USD | 60 | 71 | |
| 12 | 119.1B USD | 58 | 57 | |
| 12 | 134.5B USD | 58 | 70 | |
| 14 | 108.6B USD | 55 | 66 | |
| 15 | 100.2B USD | 54 | 57 | |
| 16 | 116.9B USD | 49 | 47 | |
| 16 | 100.2B USD | 49 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score